Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

被引：12
|
作者：
Ellis, Katrina L. [1 ,2 ]
Watts, Gerald F. [1 ,3 ]
机构：
[1] Univ Western Australia, Sch Med, 35 Stirling Highway, Crawley, WA 6009, Australia
[2] Univ Western Australia, Sch Biomed Sci, 35 Stirling Highway, Crawley, WA 6009, Australia
[3] Royal Perth Hosp, Dept Cardiol, Lipid Disorders Clin, GPO Box X2213, Perth, WA 6001, Australia
来源：
CARDIOLOGY CLINICS | 2018年 / 36卷 / 02期
关键词：
Lipoprotein(a); Atherosclerotic cardiovascular disease; Pharmacotherapy; Risk assessment; Models of care; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; DOUBLE-BLIND; TARGETING APOLIPOPROTEIN(A); VASCULAR RISK; CORONARY; APHERESIS; DYSLIPIDEMIA; OUTCOMES; THERAPY;
D O I：
10.1016/j.ccl.2017.12.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lipoprotein(a) is a low-density lipoprotein-like particle covalently bound to a glycoprotein called apolipoprotein(a) that is under potent genetic control. Plasma levels of lipoprotein(a) vary by up to 1000-fold among individuals, with 1 in 4 having levels that increase the risk of atherosclerotic cardiovascular disease. New evidence supports a causal role for lipoprotein(a) in atherosclerotic cardiovascular disease and aortic valve stenosis. Individuals with elevated lipoprotein(a) have a high life-time burden of atherosclerotic cardiovascular disease. This notion is important for coronary prevention. But is lipoprotein(a) ready for prime-time use in coronary prevention clinics?
引用
收藏
页码：287 / +
页数：13
相关论文
共 50 条
  • [21] Rapid diagnosis of invasive candidiasis: ready for prime-time?
    Clancy, Cornelius J.
    Minh-Hong Nguyen
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 546 - 552
  • [22] Lymphatic Mapping for Vulvar Cancer: Ready for "Prime-Time?"
    Coleman, Robert L.
    [J]. CURRENT ONCOLOGY REPORTS, 2008, 10 (06) : 493 - 496
  • [23] C-EPO: Ready for prime-time preconditioning?
    Kennedy, J
    Buchan, AM
    [J]. CEREBROVASCULAR DISEASES, 2005, 19 (04) : 272 - 273
  • [24] THE REVISED UNIFORM PARTNERSHIP ACT - NOT READY FOR PRIME-TIME
    RIBSTEIN, LE
    [J]. BUSINESS LAWYER, 1993, 49 (01): : 45 - 82
  • [25] Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
    Alexandra R Lewis
    Juan W Valle
    Mairead G Mc Namara
    [J]. World Journal of Gastroenterology, 2016, 22 (32) : 7175 - 7185
  • [26] PARALLEL I/O - GETTING READY FOR PRIME-TIME
    REED, D
    CATLETT, C
    CHOUDHARY, A
    KOTZ, D
    SNIR, M
    [J]. IEEE PARALLEL & DISTRIBUTED TECHNOLOGY, 1995, 3 (02): : 64 - 71
  • [27] Is robotic pancreatic surgery finally ready for prime-time?
    Gumbs, Andrew A.
    Croner, Roland
    Chouillard, Elie
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (05) : 650 - 653
  • [28] Lymphatic mapping for vulvar cancer: Ready for “Prime-Time?”
    Robert L. Coleman
    [J]. Current Oncology Reports, 2008, 10 : 493 - 496
  • [29] Alport Syndrome Therapeutics: Ready for Prime-Time Players
    Omachi, Kohei
    Miner, Jeffrey H.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (11) : 803 - 806
  • [30] Targeting the follicular lymphoma microenvironment - Ready for prime-time?
    Cheung, Matthew C.
    Imrie, Kevin R.
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 837 - 838
12345